NCCN Guidelines for Patients® | Mantle Cell Lymphoma

42 NCCN Guidelines for Patients ® : Mantle Cell Lymphoma, 2019 Index Index antibody treatment 13 BCL-2 inhibitor 13 blood tests 17, 20, 22–23 bone marrow biopsy 16, 19 bone marrow aspiration 19 chemoimmunotherapy 13, 18, 22, 24–25, 27 chemotherapy 13–16, 26 chromosome 9, 11–12 clinical trial 13–14, 24–26, 31 complete response 22–27 consolidation 24, 26–27 corticosteroid 13–14 diagnosis 11–12, 19, 22, 30 fertility 16, 20 heart tests 19–20 imaging 18–20, 22–23, 34 immunomodulator 13–14, 26–27 induction 24–27 involved-site radiation therapy 14, 24, 26 kinase inhibitor 13, 26–27 maintenance 24–27 medical history 16, 23 NCCN Cancer Centers 41 NCCN Contributors 40 physical exam 16–17, 23 relapse 14, 23, 26–27 side effect 27 stem cell transplant 14, 22, 24, 27 supportive care 22–23, 27

RkJQdWJsaXNoZXIy NTYwNTM=